AHMED, Nabil, M.,BIELAMOWICZ, Kevin,FOUSEK, Kristen
申请号：
EP16743974
公开号：
EP3250695A4
申请日:
2016.01.26
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
Embodiments of the disclosure encompass adoptive immunotherapy related to cells expressing multiple chimeric antigen receptors (CARs). In specific embodiments, T cells express a HER2-specific CAR, an IL13 Rα2-specific CAR, and an EphA2-specific CAR. In particular embodiments, the cells are utilized for cancer treatment, including for glioblastoma.
